CYTOSORBENTS CORPORATION Inventory
CYTOSORBENTS CORPORATION (CTSO) had Inventory of $3.69 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-06
- 2026-06-30: Inventory, Net $3.69M.
- 2026-03-31: Inventory, Net $4.48M.
- 2025-12-31: Inventory, Net $5.28M.
- 2025-09-30: Inventory, Net $4.00M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $3.69M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $4.48M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $5.28M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $4.00M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.71M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.02M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.73M 10-K · filed 2026-03-30 | $2.73M 10-K · filed 2025-03-31 |
| 2024-09-30 | $3.25M 10-K · filed 2025-03-31 | |
| 2024-06-30 | $4.32M 10-K · filed 2025-03-31 | |
| 2024-03-31 | $3.74M 10-K · filed 2025-03-31 | |
| 2023-12-31 | $3.38M 10-K · filed 2025-03-31 | $3.68M 10-K · filed 2024-03-15 |
| 2023-09-30 | $2.98M 10-K · filed 2025-03-31 | |
| 2023-06-30 | $2.05M 10-K · filed 2025-03-31 | |
| 2023-03-31 | $1.73M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $3.46M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $3.54M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $4.98M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $5.45M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $4.77M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $4.53M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $3.69M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $3.11M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $2.67M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $2.02M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $1.99M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $1.97M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $2.11M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $1.77M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.46M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.21M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $833.13K 10-K · filed 2020-03-05 | |
| 2018-09-30 | $779.42K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $769.25K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $680.18K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $795.66K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $1.09M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $889.74K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $857.79K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $833.98K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $1.05M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $1.05M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.06M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.19M 10-K · filed 2017-03-03 | |
| 2015-09-30 | $1.34M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $1.06M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $702.92K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $537.57K 10-K · filed 2016-03-09 | |
| 2014-09-30 | $387.07K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $303.69K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $146.52K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $245.61K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $362.54K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $476.55K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $555.26K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $682.37K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $625.78K 10-Q · filed 2012-11-21 | |
| 2012-06-30 | $535.26K 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $468.56K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $431.02K 10-K · filed 2013-04-03 | |
| 2011-09-30 | $186.34K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |